Palisade Bio Cash Per Share vs. Cash And Equivalents
| PALI Stock | USD 1.44 0.38 20.88% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 27.26232089 | Current Value 25.9 | Quarterly Volatility 1.2 K |
For Palisade Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Palisade Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Palisade Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Palisade Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Palisade Bio over time as well as its relative position and ranking within its peers.
Palisade |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.26) | Return On Assets (0.59) | Return On Equity (1.10) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Palisade Bio Cash And Equivalents vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Palisade Bio's current stock value. Our valuation model uses many indicators to compare Palisade Bio value to that of its competitors to determine the firm's financial worth. Palisade Bio is rated below average in cash per share category among its peers. It is rated below average in cash and equivalents category among its peers creating about 21,739,130 of Cash And Equivalents per Cash Per Share. As of now, Palisade Bio's Cash Per Share is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Palisade Bio's earnings, one of the primary drivers of an investment's value.Palisade Cash And Equivalents vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Palisade Bio |
| = | 0.23 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Palisade Bio |
| = | 5 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Palisade Cash And Equivalents Comparison
Palisade Bio is currently under evaluation in cash and equivalents category among its peers.
Palisade Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Palisade Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Palisade Bio will eventually generate negative long term returns. The profitability progress is the general direction of Palisade Bio's change in net profit over the period of time. It can combine multiple indicators of Palisade Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -13.1 M | -13.7 M | |
| Income Before Tax | -12.3 M | -12.9 M | |
| Total Other Income Expense Net | 770 K | 808.5 K | |
| Net Loss | -12.3 M | -12.9 M | |
| Income Tax Expense | 16 K | 16.8 K | |
| Interest Income | 25.9 K | 24.6 K | |
| Net Loss | -13.1 M | -13.7 M | |
| Net Interest Income | -15 K | -15.8 K | |
| Net Loss | -12.3 M | -12.9 M | |
| Change To Netincome | 16.4 M | 17.2 M | |
| Net Loss | (26.97) | (28.32) | |
| Income Quality | 0.91 | 0.61 | |
| Net Income Per E B T | 1.03 | 1.09 |
Palisade Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Palisade Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Palisade Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Palisade Bio's important profitability drivers and their relationship over time.
Use Palisade Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Palisade Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will appreciate offsetting losses from the drop in the long position's value.Palisade Bio Pair Trading
Palisade Bio Pair Trading Analysis
The ability to find closely correlated positions to Palisade Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Palisade Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Palisade Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Palisade Bio to buy it.
The correlation of Palisade Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Palisade Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Palisade Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Palisade Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Palisade Bio position
In addition to having Palisade Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Steel Works Etc Thematic Idea Now
Steel Works Etc
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Steel Works Etc theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Steel Works Etc Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
To fully project Palisade Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Palisade Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Palisade Bio's income statement, its balance sheet, and the statement of cash flows.